Masaryk University

Publication Records

česky | in English

Filter publications

    2023

    1. Lékařská biologie II. Genetika a molekulární medicína (Medical Biology II. Genetics and molecular medicine)
      SLABÝ, Ondřej, Iva SLANINOVÁ, David ŠMAJS, Jiří ŠÁNA, Vladimír ROTREKL, Pavel KREJČÍ, Stjepan ULDRIJAN, Juraj BOSÁK, Kateřina SLABÁ and Sabina ŠEVČÍKOVÁ. Lékařská biologie II. Genetika a molekulární medicína (Medical Biology II. Genetics and molecular medicine). 1st ed. Brno: Masarykova univerzita, 2023, 227 pp. ISBN 978-80-280-0338-8.
      More: https://is.muni.cz/publication/2305130/en
    2. Nanodiamonds as artificial proteins for regulation of a cell signalling system
      CÍGLER, Petr, Lukáš BÁLEK, Jan HAVLÍK, Pavel KREJČÍ, Lukáš TRANTÍREK and Silvie TRANTÍRKOVÁ. Nanodiamonds as artificial proteins for regulation of a cell signalling system. 2023.
      More: https://is.muni.cz/publication/2364737/en
    3. Nanodiamonds as artificial proteins for regulation of a cell signalling system
      CÍGLER, Petr, Lukáš BÁLEK, Jan HAVLÍK, Pavel KREJČÍ, Lukáš TRANTÍREK and Silvie TRANTÍRKOVÁ. Nanodiamonds as artificial proteins for regulation of a cell signalling system. 2023.
      More: https://is.muni.cz/publication/2302565/en
    4. Skeletal diseases caused by mutations in PTH1R show aberrant differentiation of skeletal progenitors due to dysregulation of DEPTOR
      CSUKASI, Fabiana, Michaela BOSÁKOVÁ, Tomáš BÁRTA, Jorge H MARTIN, Jesus ARCEDO, Maya BARAD, Gustavo A RICO-LLANOS, Jennifer ZIEBA, Jose BECERRA, Pavel KREJČÍ, Ivan DURAN and Deborah KRAKOW. Skeletal diseases caused by mutations in PTH1R show aberrant differentiation of skeletal progenitors due to dysregulation of DEPTOR. Frontiers in Cell and Developmental Biology. Lausanne: Frontiers Media S.A., 2023, vol. 10, January 2023, p. 1-13. ISSN 2296-634X. Available from: https://dx.doi.org/10.3389/fcell.2022.963389.
      More: https://is.muni.cz/publication/2292988/en
    5. Thermostable FGF2 polypeptide, use thereof
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 polypeptide, use thereof. 2023.
      More: https://is.muni.cz/publication/2354741/en
    6. Thermostable FGF2 polypeptide, use thereof
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 polypeptide, use thereof. 2023.
      More: https://is.muni.cz/publication/2285102/en
    7. Thermostable FGF2 Polypeptide, Use Thereof
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 Polypeptide, Use Thereof. 2023.
      More: https://is.muni.cz/publication/2386677/en

    2022

    1. 熱安定性ＦＧＦ２ポリペプチド及びその使用 (Thermostable FGF2 polypeptide, use thereof)
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. 熱安定性ＦＧＦ２ポリペプチド及びその使用 (Thermostable FGF2 polypeptide, use thereof). 2022.
      More: https://is.muni.cz/publication/2269137/en
    2. A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic
      PEŠL, Martin, Hana VEREŠČÁKOVÁ, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic. Orphanet Journal of Rare Diseases. London: England, 2022, vol. 17, No 1, p. 1-7. ISSN 1750-1172. Available from: https://dx.doi.org/10.1186/s13023-022-02374-x.
      More: https://is.muni.cz/publication/1875158/en
    3. Cilia kinases in skeletal development and homeostasis
      POOVAKULATHU ABRAHAM, Sara, Alexandru NITĂ, Pavel KREJČÍ and Michaela BOSÁKOVÁ. Cilia kinases in skeletal development and homeostasis. Developmental dynamics. United States: Wiley-Liss, 2022, vol. 251, No 4, p. 577-608. ISSN 1058-8388. Available from: https://dx.doi.org/10.1002/dvdy.426.
      More: https://is.muni.cz/publication/1809357/en
    4. Expanding horizons of achondroplasia treatment: current options and future developments
      FAFÍLEK, Bohumil, Michaela BOSÁKOVÁ and Pavel KREJČÍ. Expanding horizons of achondroplasia treatment: current options and future developments. Osteoarthritis and Cartilage. Oxford: Elsevier, 2022, vol. 30, No 4, p. 535-544. ISSN 1063-4584. Available from: https://dx.doi.org/10.1016/j.joca.2021.11.017.
      More: https://is.muni.cz/publication/1818487/en
    5. Intervertebral disc degeneration is rescued by TGFβ/BMP signaling modulation in an ex vivo filamin B mouse model
      ZIEBA, J., K. N. FORLENZA, K. HEARD, J. H. MARTIN, Michaela BOSÁKOVÁ, D. H. COHN, S. P. ROBERTSON, Pavel KREJČÍ and D. KRAKOW. Intervertebral disc degeneration is rescued by TGFβ/BMP signaling modulation in an ex vivo filamin B mouse model. Bone research. London: SPRINGERNATURE, 2022, vol. 10, No 1, p. 1-12. ISSN 2095-4700. Available from: https://dx.doi.org/10.1038/s41413-022-00200-5.
      More: https://is.muni.cz/publication/1850798/en
    6. LuminoCell: a versatile and affordable platform for real-time monitoring of luciferase-based reporters
      WEISSOVÁ, Kamila, Bohumil FAFÍLEK, Tomasz Witold RADASZKIEWICZ, Canan ÇELIKER, Petra MACHÁČKOVÁ, Tamara ČECHOVÁ, Jana ŠEBESTÍKOVÁ, Aleš HAMPL, Vítězslav BRYJA, Pavel KREJČÍ and Tomáš BÁRTA. LuminoCell: a versatile and affordable platform for real-time monitoring of luciferase-based reporters. Life science alliance. COLD SPRING HARBOR: LIFE SCIENCE ALLIANCE LLC, 2022, vol. 5, No 8, p. 1-9. ISSN 2575-1077. Available from: https://dx.doi.org/10.26508/lsa.202201421.
      More: https://is.muni.cz/publication/1850799/en
    7. Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells
      DAVE, Zankruti, Olga VONDÁLOVÁ BLANÁŘOVÁ, Štěpán ČADA, Pavlína JANOVSKÁ, Nikodém ZEZULA, Martin BĚHAL, Kateřina HANÁKOVÁ, Sri Ranjani GANJI, Pavel KREJČÍ, Kristína GÖMÖRYOVÁ, Helena PESCHELOVÁ, Michal ŠMÍDA, Zbyněk ZDRÁHAL, Šárka PAVLOVÁ, Jana KOTAŠKOVÁ, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells. Frontiers in Cell and Developmental Biology. Frontiers Media SA, 2022, vol. 10, February 2022, p. 1-11. ISSN 2296-634X. Available from: https://dx.doi.org/10.3389/fcell.2022.838871.
      More: https://is.muni.cz/publication/1843559/en
    8. Nanodiamonds as traps for fibroblast growth factors: Parameters influencing the interaction
      MIKESOVA, Jana, Daria MILIAIEVA, Pavla STENCLOVA, Marek KINDERMANN, Tereza VUCKOVA, Marcela MADLIKOVA, Milan FABRY, Vaclav VEVERKA, Jiri SCHIMER, Pavel KREJČÍ, Stepan STEHLIK and Petr CIGLER. Nanodiamonds as traps for fibroblast growth factors: Parameters influencing the interaction. Carbon. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2022, vol. 195, No 15, p. 372-386. ISSN 0008-6223. Available from: https://dx.doi.org/10.1016/j.carbon.2022.04.017.
      More: https://is.muni.cz/publication/1875148/en
    9. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta
      DURAN, I., J. ZIEBA, F. CSUKASI, J. H. MARTIN, D. WACHTELL, M. BARAD, B. DAWSON, Bohumil FAFÍLEK, C. M. JACOBSEN, C. G. AMBROSE, D. H. COHN, Pavel KREJČÍ, B. H. LEE and D. KRAKOW. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta. Journal of bone and mineral research. Hoboken: Wiley, 2022, vol. 37, No 4, p. 675-686. ISSN 0884-0431. Available from: https://dx.doi.org/10.1002/jbmr.4501.
      More: https://is.muni.cz/publication/1850800/en

    2021

    1. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
      KIMURA, T., Michaela BOSÁKOVÁ, Y. NONAKA, Eva HRUBA, K. YASUDA, S. FUTAKAWA, T. KUBOTA, Bohumil FAFÍLEK, Tomáš GREGOR, Sara POOVAKULATHU ABRAHAM, Regína GOMOLKOVÁ, Silvie BELASKOVA, Martin PEŠL, F. CSUKASI, I. DURAN, M. FUJIWARA, Michaela KAVKOVA, Tomas ZIKMUND, Josef KAISER, Marcela BUCHTOVÁ, D. KRAKOW, Y. NAKAMURA, K. OZONO and Pavel KREJČÍ. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice. Science Translational Medicine. Washington: American Association for the Advancement of Science, 2021, vol. 13, No 592, p. "eaba4226", 14 pp. ISSN 1946-6234. Available from: https://dx.doi.org/10.1126/scitranslmed.aba4226.
      More: https://is.muni.cz/publication/1785579/en
    2. Loss of Sprouty produces a ciliopathic skeletal phenotype in mice through elongation of primary cilia and upregulation of Hedgehog signaling
      HRUBÁ, Eva, Michaela KAVKOVÁ, Linda DALECKÁ, Miloš MACHOLÁN, Tomáš ZIKMUND, Miroslav VAŘECHA, Michaela BOSÁKOVÁ, Jozef KAISER, Pavel KREJČÍ, Mária HOVOŘÁKOVÁ and Marcela BUCHTOVÁ. Loss of Sprouty produces a ciliopathic skeletal phenotype in mice through elongation of primary cilia and upregulation of Hedgehog signaling. In 2nd CONFERENCE OF THE VISEGRÁD GROUP SOCIETY FOR DEVELOPMENTAL BIOLOGY. 2021.
      More: https://is.muni.cz/publication/1844179/en
    3. Loss of Sprouty Produces a Ciliopathic Skeletal Phenotype in Mice Through Upregulation of Hedgehog Signaling
      HRUBÁ, Eva, Michaela KAVKOVÁ, Linda DALECKÁ, Miloš MACHOLÁN, Tomáš ZIKMUND, Miroslav VAŘECHA, Michaela BOSÁKOVÁ, Jozef KAISER, Pavel KREJČÍ, Mária HOVOŘÁKOVÁ and Marcela BUCHTOVÁ. Loss of Sprouty Produces a Ciliopathic Skeletal Phenotype in Mice Through Upregulation of Hedgehog Signaling. Journal of Bone and Mineral Research. American Society for Bone and Mineral Research, 2021, vol. 36, No 11, p. 2258-2274. ISSN 0884-0431. Available from: https://dx.doi.org/10.1002/jbmr.4427.
      More: https://is.muni.cz/publication/1797299/en
    4. Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
      NITA, Alexandru, Sara POOVAKULATHU ABRAHAM, Pavel KREJČÍ and Michaela BOSÁKOVÁ. Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling. Cells. Basel: MDPI, 2021, vol. 10, No 6, p. 1-25. ISSN 2073-4409. Available from: https://dx.doi.org/10.3390/cells10061445.
      More: https://is.muni.cz/publication/1785577/en
    5. REGISTRY OF ACHONDROPLASIA 2015–2021
      PEŠL, Martin, Hana VEREŠČÁKOVÁ, J KOTRYLOVÁ and Pavel KREJČÍ. REGISTRY OF ACHONDROPLASIA 2015–2021. In The 23rd Prague-Lublin-Sydney- -St Petersburg Symposium Locomotor Apparatus Adaptation II – Interdisciplinary Aspects. 2021. ISSN 2336-4777.
      More: https://is.muni.cz/publication/1814957/en
    6. Thermostable FGF2 polypeptide, use thereof
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 polypeptide, use thereof. 2021.
      More: https://is.muni.cz/publication/1845598/en
    7. Thermostable FGF2 Polypeptide, Use Thereof
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 Polypeptide, Use Thereof. 2021.
      More: https://is.muni.cz/publication/1770461/en
    8. Ztráta Sprouty2/4 u myší vede k ciliopatickému fenotypu
      BUCHTOVÁ, Marcela, Eva HRUBÁ, Michaela KAVKOVÁ, Linda DALECKÁ, Miloš MACHOLÁN, Tomáš ZIKMUND, Michaela BOSÁKOVÁ, Pavel KREJČÍ and Mária HOVOŘÁKOVÁ. Ztráta Sprouty2/4 u myší vede k ciliopatickému fenotypu. In XXIV. BIOLOGICKÉ DNY 2021 OD SAVČÍ VÝVOJOVÉ BIOLOGIE PO REPRODUKČNÍ MEDICÍNU. 2021.
      More: https://is.muni.cz/publication/1844982/en

    2020

    1. Biallelic mutations in LAMA5 disrupts a skeletal noncanonical focal adhesion pathway and produces a distinct bent bone dysplasia
      BARAD, M., F. CSUKASI, Michaela BOSÁKOVÁ, J. H. MARTIN, W. J. ZHANG, S. P. TAYLOR, R. S. LACHMAN, J. ZIEBA, M. BAMSHAD, D. NICKERSON, J. X. CHONG, D. H. COHN, Pavel KREJČÍ, D. KRAKOW and I. DURAN. Biallelic mutations in LAMA5 disrupts a skeletal noncanonical focal adhesion pathway and produces a distinct bent bone dysplasia. EBioMedicine. Amsterdam: Elsevier Science BV, 2020, vol. 62, DEC 2020, p. 1-13. ISSN 2352-3964. Available from: https://dx.doi.org/10.1016/j.ebiom.2020.103075.
      More: https://is.muni.cz/publication/1727498/en
    2. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex
      GREGOR, Tomáš, Michaela BOSÁKOVÁ, Alexandru NITĂ, Sara POOVAKULATHU ABRAHAM, Bohumil FAFÍLEK, Nicole ČERNOHORSKÁ, Jan RYNEŠ, Silvie TRANTÍRKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Lukáš TRANTÍREK and Pavel KREJČÍ. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex. Cellular and molecular life sciences. BASEL: SPRINGER BASEL AG, 2020, vol. 77, No 19, p. 3885-3903. ISSN 1420-682X. Available from: https://dx.doi.org/10.1007/s00018-019-03397-7.
      More: https://is.muni.cz/publication/1681537/en
    3. Mutations in GRK2 cause Jeune syndrome by impairing Hedgehog and canonical Wnt signaling
      BOSÁKOVÁ, Michaela, Sara POOVAKULATHU ABRAHAM, Alexandru NITĂ, Eva HRUBA, Marcela BUCHTOVA, S. Paige TAYLOR, Ivan DURAN, Jorge MARTIN, Kateřina SVOZILOVÁ, Tomáš BÁRTA, Miroslav VAŘECHA, Lukáš BÁLEK, Jiri KOHOUTEK, Tomasz Witold RADASZKIEWICZ, Ganesh V. PUSAPATI, Vítězslav BRYJA, Eric T. RUSH, Isabelle THIFFAULT, Deborah A. NICKERSON, Michael J. BAMSHAD, Rajat ROHATGI, Daniel H. COHN, Deborah KRAKOW and Pavel KREJČÍ. Mutations in GRK2 cause Jeune syndrome by impairing Hedgehog and canonical Wnt signaling. EMBO MOLECULAR MEDICINE. HOBOKEN: WILEY-BLACKWELL, 2020, vol. 12, No 11, p. 1-20. ISSN 1757-4676. Available from: https://dx.doi.org/10.15252/emmm.201911739.
      More: https://is.muni.cz/publication/1688918/en
    4. Thermostable FGF2 Polypeptide, Use Thereof
      DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 Polypeptide, Use Thereof. 2020.
      More: https://is.muni.cz/publication/1339462/en

    2019

    1. C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
      KREJČÍ, Pavel. C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2019, vol. 381, No 13, p. 1291. ISSN 0028-4793. Available from: https://dx.doi.org/10.1056/NEJMc1910394.
      More: https://is.muni.cz/publication/1605051/en
    2. Deficiency of Sprouty Proteins in Mice Resemble Ciliopathic Phenotype
      HRUBA, E., M. KAVKOVA, T. ZIKMUND, M. HOVORAKOVA, L. DALECKA, Michaela BOSÁKOVÁ, Pavel KREJČÍ and M. BUCHTOVA. Deficiency of Sprouty Proteins in Mice Resemble Ciliopathic Phenotype. In International Congress of Vertebrate Morphology (ICVM). 2019. ISSN 0362-2525.
      More: https://is.muni.cz/publication/1605048/en
    3. Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase
      BOSÁKOVÁ, Michaela, Alexandru NITĂ, Tomáš GREGOR, Miroslav VAŘECHA, Iva GUDERNOVÁ, Bohumil FAFÍLEK, Tomáš BÁRTA, Neha BASHEER, Sara POOVAKULATHU ABRAHAM, Lukáš BÁLEK, Markéta TOMANOVÁ, Jana FIALOVÁ KUČEROVÁ, Juraj BOSÁK, David POTĚŠIL, Jennifer ZIEBA, Jieun SONG, Peter KONIK, Sohyun PARK, Ivan DURAN, Zbyněk ZDRÁHAL, David ŠMAJS, Gert JANSEN, Zheng FU, Hyuk Wan KO, Aleš HAMPL, Lukáš TRANTÍREK, Deborah KRAKOW and Pavel KREJČÍ. Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase. Proceedings of the National Academy of Sciences of the United States of America. WASHINGTON: NATL ACAD SCIENCES, 2019, vol. 116, No 10, p. 4316-4325. ISSN 0027-8424. Available from: https://dx.doi.org/10.1073/pnas.1800338116.
      More: https://is.muni.cz/publication/1531598/en

    2018

    1. Colicin F-Y inhibits pathogenic Yersinia enterocolitica in mice
      BOSÁK, Juraj, Lenka MICENKOVÁ, Matěj HRALA, Katarína POMORSKÁ, Michaela BOSÁKOVÁ, Pavel KREJČÍ, Eduard GÖPFERT, Martin FALDYNA and David ŠMAJS. Colicin F-Y inhibits pathogenic Yersinia enterocolitica in mice. Scientific reports. London: NATURE PUBLISHING GROUP, 2018, vol. 8, No 12242, p. 1-12. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-018-30729-7.
      More: https://is.muni.cz/publication/1461576/en
    2. Computer-assisted engineering of hyperstable fibroblast growth factor 2
      DVOŘÁK, Pavel, David BEDNÁŘ, Pavel VAŇÁČEK, Lukáš BÁLEK, Lívia EISELLEOVÁ, Veronika ŠTĚPÁNKOVÁ, Eva ŠEBESTOVÁ, Michaela BOSÁKOVÁ, Žaneta KONEČNÁ, Stanislav MAZURENKO, Antonín KUNKA, Tereza VÁŇOVÁ, Karolína ZOUFALOVÁ, Radka CHALOUPKOVÁ, Jan BREZOVSKÝ, Pavel KREJČÍ, Zbyněk PROKOP, Petr DVOŘÁK and Jiří DAMBORSKÝ. Computer-assisted engineering of hyperstable fibroblast growth factor 2. Biotechnology and Bioengineering. New York: Wiley, 2018, vol. 115, No 4, p. 850-862. ISSN 0006-3592. Available from: https://dx.doi.org/10.1002/bit.26531.
      More: https://is.muni.cz/publication/1417222/en
    3. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells
      GHOSH, Somadri, Samuel SCOZZARO, Ana Raque RAMOS, Seprimebastien DELCAMBRE, Cleprimement CHEVALIER, Pavel KREJČÍ and Christophe ERNEUX. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells. Journal of Cell Science. Cambridge: Company of Biologists Ltd., 2018, vol. 131, No 16, p. 1-12. ISSN 0021-9533. Available from: https://dx.doi.org/10.1242/jcs.216408.
      More: https://is.muni.cz/publication/1455136/en
    4. Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals
      BÁLEK, Lukáš, Marcela BUCHTOVÁ, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Silvie TRANTÍRKOVÁ, Iva GUDERNOVÁ, Iva VESELÁ, Jan HAVLIK, Jitka NEBURKOVA, Stuart TURNER, Mateusz Adam KRZYSCIK, Malgorzata ZAKRZEWSKA, Lars KLIMASCHEWSKI, Peter CLAUS, Lukáš TRANTÍREK, Petr CIGLER and Pavel KREJČÍ. Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals. Biomaterials. OXFORD: ELSEVIER SCI LTD, 2018, vol. 176, SEP 2018, p. 106-121. ISSN 0142-9612. Available from: https://dx.doi.org/10.1016/j.biomaterials.2018.05.030.
      More: https://is.muni.cz/publication/1490507/en
    5. Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome
      BÁLEK, Lukáš, Pavel NĚMEC, P. KONIK, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Iva GUDERNOVÁ, Jiřina MEDALOVÁ, Deborah KRAKOW and Pavel KREJČÍ. Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome. Cellular Signalling. New York: Elsevier Science, 2018, vol. 42, JAN 2018, p. 144-154. ISSN 0898-6568. Available from: https://dx.doi.org/10.1016/j.cellsig.2017.10.003.
      More: https://is.muni.cz/publication/1395567/en
    6. Registr Achondroplasie na Slovensku a v České republice
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. Registr Achondroplasie na Slovensku a v České republice. In Stretnutie Palčekov v Bojniciach - Hlbokom. 2018.
      More: https://is.muni.cz/publication/1442176/en
    7. Registr Achondroplázie REACH
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. Registr Achondroplázie REACH. In Den Vzácných Onemocnění 2018. 2018.
      More: https://is.muni.cz/publication/1411814/en
    8. Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies
      BOSÁKOVÁ, Michaela, Miroslav VAŘECHA, Marek HAMPL, Ivan DURAN, Alexandru NITĂ, Marcela BUCHTOVÁ, Hana DOSEDELOVA, Radek MACHÁT, Yangli XIE, Zhenhong NI, Jorge H. MARTIN, Lin CHEN, Gert JANSEN, Deborah KRAKOW and Pavel KREJČÍ. Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies. Human molecular genetics. OXFORD: OXFORD UNIV PRESS, 2018, vol. 27, No 6, p. 1093-1105. ISSN 0964-6906. Available from: https://dx.doi.org/10.1093/hmg/ddy031.
      More: https://is.muni.cz/publication/1490536/en
    9. The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases
      FAFÍLEK, Bohumil, Lukáš BÁLEK, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Alexandru NITĂ, Tomáš GREGOR, Iva GUDERNOVÁ, Jitka KŘENOVÁ, S. GHOSH, Martin PISKÁČEK, Lucie JONATOVA, Nicole ČERNOHORSKÁ, J.T. ZIEBA, M. KOSTAS, E.M. HAUGSTEN, J. WESCHE, C. ERNEUX, Lukáš TRANTÍREK, D. KRAKOW and Pavel KREJČÍ. The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases. SCIENCE SIGNALING. WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE, 2018, vol. 11, No 548, p. 1-14. ISSN 1945-0877. Available from: https://dx.doi.org/10.1126/scisignal.aap8608.
      More: https://is.muni.cz/publication/1490481/en
    10. The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling
      CSUKASI, F., I. DURAN, M. BARAD, Tomáš BÁRTA, Iva GUDERNOVÁ, Lukáš TRANTÍREK, J.H. MARTIN, C.Y. KUO, J. WOODS, H. LEE, D.H. COHN, Pavel KREJČÍ and D. KRAKOW. The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling. Science Translational Medicine. Washington: American Association for the Advancement of Science, 2018, vol. 10, No 459, p. 1-11. ISSN 1946-6234. Available from: https://dx.doi.org/10.1126/scitranslmed.aat9356.
      More: https://is.muni.cz/publication/1490193/en

    2017

    1. A Chaperone Complex Formed by HSP47, FKBP65 and BiP Modulates Telopeptide Lysyl Hydroxylation of Type I Procollagen
      DURAN, Ivan, Jorge H. MARTIN, Mary Ann WEIS, Pavel KREJČÍ, Peter KONIK, Bing LI, Yasemin ALANAY, Caressa LIETMAN, Brendan LEE, David EYRE, Daniel H. COHN and Deborah KRAKOW. A Chaperone Complex Formed by HSP47, FKBP65 and BiP Modulates Telopeptide Lysyl Hydroxylation of Type I Procollagen. Journal of Bone and Mineral Research. Hoboken: Wiley-Blackwell, 2017, vol. 32, No 6, p. 1309-1319. ISSN 0884-0431. Available from: https://dx.doi.org/10.1002/jbmr.3095.
      More: https://is.muni.cz/publication/1376738/en
    2. A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation
      BERNATÍK, Ondřej, Tomasz Witold RADASZKIEWICZ, Martin BĚHAL, Zankruti DAVE, Florian WITTE, Annika MAHL, Nicole ČERNOHORSKÁ, Pavel KREJČÍ, Sigmar STRICKER and Vítězslav BRYJA. A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation. Frontiers in Cell and Developmental Biology. Lausanne: Frontiers Media S.A., 2017, vol. 5, MAY, p. 1-9. ISSN 2296-634X. Available from: https://dx.doi.org/10.3389/fcell.2017.00047.
      More: https://is.muni.cz/publication/1383089/en
    3. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3
      BÁLEK, Lukáš, Iva GUDERNOVÁ, Iva VESELA, Marek HAMPL, Veronika ORALOVÁ, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Pavel NĚMEC, Terence HALL, Giovanni ABBADESSA, Nan HATCH, marcela BUCHTOVÁ and Pavel KREJČÍ. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3. Bone. NEW YORK: Elsevier, 2017, vol. 105, DEC 2017, p. 57-66. ISSN 8756-3282. Available from: https://dx.doi.org/10.1016/j.bone.2017.08.016.
      More: https://is.muni.cz/publication/1399055/en
    4. Differences in anterior-posterior sensitivity of early limb bud cell to FGF/WNT treatment
      KILLINGER, Michael, Eva HRUBÁ, Miroslav VAŘECHA, Pavel KREJČÍ and marcela BUCHTOVÁ. Differences in anterior-posterior sensitivity of early limb bud cell to FGF/WNT treatment. In BSDB/Nordic conference on developmental biology and regeneration. 2017.
      More: https://is.muni.cz/publication/1410505/en
    5. Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480
      GUDERNOVÁ, Iva, Lukáš BÁLEK, Miroslav VAŘECHA, Jana FIALOVÁ KUČEROVÁ, Michaela BOSÁKOVÁ, Bohumil FAFÍLEK, Veronika PALUŠOVÁ, Stjepan ULDRIJAN, Lukáš TRANTÍREK and Pavel KREJČÍ. Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480. Oncotarget. New York: Impact Journals LLC, 2017, vol. 8, No 65, p. 109319-109331. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.22674.
      More: https://is.muni.cz/publication/1404487/en
    6. One reporter for in-cell activity profiling of majority of protein kinase oncogenes
      GUDERNOVÁ, Iva, Silvie TRANTÍRKOVÁ, Barbora EL GHANNAMOVÁ, Bohumil FAFÍLEK, Miroslav VAŘECHA, Lukáš BÁLEK, Eva HRUBÁ, Lucie JONÁTOVÁ, Iva JELÍNKOVÁ, Michaela BOSÁKOVÁ, Lukáš TRANTÍREK, Jiří MAYER and Pavel KREJČÍ. One reporter for in-cell activity profiling of majority of protein kinase oncogenes. eLife. Cambridge: eLife Sciences Publications Ltd., 2017, vol. 6, "e21536", p. 1-14. ISSN 2050-084X. Available from: https://dx.doi.org/10.7554/eLife.21536.
      More: https://is.muni.cz/publication/1380705/en
    7. REACH Registr Achondroplázie v roce 2017
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. REACH Registr Achondroplázie v roce 2017. In Celostátní konference Paleček 2017. 2017.
      More: https://is.muni.cz/publication/1380783/en
    8. Registr Achondroplasie a možnosti léčby souvisejících poruch růstu
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. Registr Achondroplasie a možnosti léčby souvisejících poruch růstu. In BRNĚNSKÝ GENETICKÝ DEN 2017. 2017.
      More: https://is.muni.cz/publication/1391670/en
    9. Role of Primary Cilia in Odontogenesis
      HAMPL, Marek, P. CELA, H.L. SZABO-ROGERS, Michaela BOSÁKOVÁ, H. DOSEDELOVA, Pavel KREJČÍ and marcela BUCHTOVÁ. Role of Primary Cilia in Odontogenesis. Journal of Dental Research. THOUSAND OAKS, CA USA: SAGE PUBLICATIONS INC, 2017, vol. 96, No 9, p. 965-974. ISSN 0022-0345. Available from: https://dx.doi.org/10.1177/0022034517713688.
      More: https://is.muni.cz/publication/1388291/en
    10. Statins do not inhibit the FGFR signaling in chondrocytes
      FAFÍLEK, Bohumil, Marek HAMPL, Nikola ŘIČÁNKOVÁ, I. VESELA, Lukáš BÁLEK, Michaela BOSÁKOVÁ, Iva GUDERNOVÁ, Miroslav VAŘECHA, marcela BUCHTOVÁ and Pavel KREJČÍ. Statins do not inhibit the FGFR signaling in chondrocytes. Osteoarthritis and Cartilage. Oxford: Elsevier Science Inc., 2017, vol. 25, No 9, p. 1522-1530. ISSN 1063-4584. Available from: https://dx.doi.org/10.1016/j.joca.2017.05.014.
      More: https://is.muni.cz/publication/1388208/en
    11. Systematic analysis of BCR-ABL interactome in chronic myeloid leukemia
      GREGOR, Tomáš, Jan RYNEŠ, Silvie TRANTÍRKOVÁ, Jiří MAYER, Pavel KREJČÍ and Lukáš TRANTÍREK. Systematic analysis of BCR-ABL interactome in chronic myeloid leukemia. In 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back. 2017. ISSN 1742-464X.
      More: https://is.muni.cz/publication/1411821/en
    12. Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion
      VÁŇOVÁ, Tereza, Žaneta KONEČNÁ, Zuzana ZBOŇÁKOVÁ, Giuseppe LA VENUTA, Karolína ZOUFALOVÁ, Šárka JELÍNKOVÁ, Miroslav VAŘECHA, Vladimír ROTREKL, Pavel KREJČÍ, Walter NICKEL, Petr DVOŘÁK and Michaela BOSÁKOVÁ. Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion. Stem Cells. UNITED STATES: WILEY-BLACKWELL, 2017, vol. 35, No 9, p. 2050-2059. ISSN 1066-5099. Available from: https://dx.doi.org/10.1002/stem.2660.
      More: https://is.muni.cz/publication/1389283/en

    2016

    1. An inactivating mutation in intestinal cell kinase, ICK, impairs hedgehog signalling and causes short rib-polydactyly syndrome
      TAYLOR, S. Paige, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Lukáš BÁLEK, Tomáš BÁRTA, Lukáš TRANTÍREK, Iva JELÍNKOVÁ, Ivan DURAN, Iva VESELÁ, Kimberly N. FORLENZA, Jorge H. MARTIN, Aleš HAMPL, Michael BAMSHAD, Deborah NICKERSON, Margie L. JAWORSKI, Jieun SONG, Hyuk WAN KO, Daniel H. COHN, Deborah KRAKOW and Pavel KREJČÍ. An inactivating mutation in intestinal cell kinase, ICK, impairs hedgehog signalling and causes short rib-polydactyly syndrome. Human Molecular Genetics. Oxford: Oxford University Press, 2016, vol. 25, No 18, p. 3998-4011. ISSN 0964-6906. Available from: https://dx.doi.org/10.1093/hmg/ddw240.
      More: https://is.muni.cz/publication/1362765/en
    2. Effect of WNT5a and WNT7a on chondrogenesis during limb development
      KILLINGER, Michael, Petra CELÁ, Pavel KREJČÍ and marcela BUCHTOVÁ. Effect of WNT5a and WNT7a on chondrogenesis during limb development. In EMBO Conference: Wnt Meeting 2016. 2016.
      More: https://is.muni.cz/publication/1374016/en
    3. MORN5 Expression during Craniofacial Development and Its Interaction with the BMP and TGF beta Pathways
      CELÁ, Petra, Marek HAMPL, Katherine K. FU, Michaela BOSÁKOVÁ, Pavel KREJČÍ, Joy M. RICHMAN and marcela BUCHTOVÁ. MORN5 Expression during Craniofacial Development and Its Interaction with the BMP and TGF beta Pathways. Frontiers in Physiology. Lausanne: FRONTIERS MEDIA SA, 2016, vol. 7, August, p. nestránkováno, 12 pp. ISSN 1664-042X. Available from: https://dx.doi.org/10.3389/fphys.2016.00378.
      More: https://is.muni.cz/publication/1357383/en
    4. Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short stature syndromes (Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes)
      GUDERNOVÁ, Iva, Iva VESELA, Lukáš BÁLEK, marcela BUCHTOVÁ, Hana DOSEDELOVA, Michaela KUNOVÁ, Jakub PIVNIČKA, Iva JELÍNKOVÁ, Lucie ROUBALOVA, Alois KOZUBÍK and Pavel KREJČÍ. Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short stature syndromes (Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes). Human Molecular Genetics. Oxford: Oxford University Press, 2016, vol. 25, No 1, p. 9-23. ISSN 0964-6906. Available from: https://dx.doi.org/10.1093/hmg/ddv441.
      More: https://is.muni.cz/publication/1318543/en
    5. NOVEL THERAPEUTIC APPROACHES TO ACHONDROPLASIA AND SETTING UP CZECH REGISTRY
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ, Hana HRSTKOVÁ and Pavel KREJČÍ. NOVEL THERAPEUTIC APPROACHES TO ACHONDROPLASIA AND SETTING UP CZECH REGISTRY. In EUROPEAN SOCIETY OF PEDIATRIC CLINICAL RESEARCH MEETING 2016. 2016. ISSN 1805-4501.
      More: https://is.muni.cz/publication/1365675/en
    6. Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport
      HAUGSTEN, Ellen Margrethe, Vigdis SØRENSEN, Michaela BOSÁKOVÁ, Gustavo Antonio de SOUZA, Pavel KREJČÍ, Antoni WIEDLOCHA and Jørgen WESCHE. Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport. Journal of Proteome Research. Washington: American Chemical Society, 2016, vol. 15, No 10, p. 3841-3855. ISSN 1535-3893. Available from: https://dx.doi.org/10.1021/acs.jproteome.6b00652.
      More: https://is.muni.cz/publication/1357368/en
    7. REACH Registr Achondroplázie v roce 2016
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. REACH Registr Achondroplázie v roce 2016. In Celostátní konference Paleček 2016. 2016.
      More: https://is.muni.cz/publication/1380784/en
    8. Toward Modelling and Analysis of Transient and Sustained Behaviour of Signalling Pathways
      HAJNAL, Matej, David ŠAFRÁNEK, Martin DEMKO, Samuel PASTVA, Pavel KREJČÍ and Luboš BRIM. Toward Modelling and Analysis of Transient and Sustained Behaviour of Signalling Pathways. In Eugenio Cinquemani. Hybrid Systems Biology. HSB 2016. LNBI 9957. Neuveden: Springer International Publishing, 2016, p. 57-66. ISBN 978-3-319-47150-1. Available from: https://dx.doi.org/10.1007/978-3-319-47151-8_4.
      More: https://is.muni.cz/publication/1353254/en

    2015

    1. A novel variant of FGFR3 causes proportionate short stature
      KANT, Sarina G., Iveta ČERVENKOVÁ, Lukáš BÁLEK, Lukáš TRANTÍREK, Gijs W. E. SANTEN, Martine C. de VRIES, Hermine A. van DUYVENVOORDE, Michiel J. R. van der WIELEN, Annemieke J. M. H. VERKERK, André G. UITTERLINDEN, Sabine E. HANNEMA, Jan M. WIT, Wilma OOSTDIJK, Pavel KREJČÍ and Monique LOSEKOOT. A novel variant of FGFR3 causes proportionate short stature. European Journal od Endocrinology. Bristol: Bioscientifica LTD, 2015, vol. 172, No 6, p. 763-770. ISSN 0804-4643. Available from: https://dx.doi.org/10.1530/EJE-14-0945.
      More: https://is.muni.cz/publication/1306875/en
    2. Automated Cell Segmentation in Phase-Contrast Images based on Classification and Region Growing
      STOKLASA, Roman, Lukáš BÁLEK, Pavel KREJČÍ and Petr MATULA. Automated Cell Segmentation in Phase-Contrast Images based on Classification and Region Growing. In Proceedings of 2015 IEEE International Symposium on Biomedical Imaging, 2015. Neuveden: Engineering in Medicine and Biology Society, 2015, p. 1447-1451. ISBN 978-1-4799-2374-8. Available from: https://dx.doi.org/10.1109/ISBI.2015.7164149.
      More: https://is.muni.cz/publication/1230987/en
    3. Cross-talk of FGF and WNT signaling pathways during limb development.
      CELÁ, Petra, Michael KILLINGER, Veronika ORALOVÁ, Iva VESELÁ, Pavel KREJČÍ and marcela BUCHTOVÁ. Cross-talk of FGF and WNT signaling pathways during limb development. In 2015 cell biology ascb annual meeting. San Francisco. 2015.
      More: https://is.muni.cz/publication/1374015/en
    4. Fate of the Molar Dental Lamina in the Monophyodont Mouse
      DOSEDĚLOVÁ, Hana, Jana DUMKOVÁ, Hervé LESOT, Kristýna GLOCOVÁ, Michaela KUNOVÁ, Abigail S. TUCKER, Iva VESELÁ, Pavel KREJČÍ, František TICHÝ, Aleš HAMPL and marcela BUCHTOVÁ. Fate of the Molar Dental Lamina in the Monophyodont Mouse. Plos one. San Francisco: Public Library Science, 2015, vol. 10, No 5, p. nestránkováno, 22 pp. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0127543.
      More: https://is.muni.cz/publication/1306866/en
    5. Fibroblast growth factor and canonical WNT/beta-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage
      BUCHTOVÁ, marcela, Veronika ORALOVÁ, Anie AKLIAN, Jan MAŠEK, Iva VESELA, Zhufeng OUYANG, Tereza OBADALOVÁ, Žaneta KONEČNÁ, Tereza SPOUSTOVÁ, Tereza POSPÍŠILOVÁ, Petr MATULA, Miroslav VAŘECHA, Lukáš BÁLEK, Iva GUDERNOVÁ, Iva JELÍNKOVÁ, Ivan DURAN, Iveta ČERVENKOVÁ, Shunichi MURAKAMI, Alois KOZUBÍK, Petr DVOŘÁK, Vítězslav BRYJA and Pavel KREJČÍ. Fibroblast growth factor and canonical WNT/beta-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage. Biochimica et Biophysica Acta - Molecular Basis of Disease. Amsterdam: ELSEVIER SCIENCE BV, 2015, vol. 1852, No 5, p. 839-850. ISSN 0925-4439. Available from: https://dx.doi.org/10.1016/j.bbadis.2014.12.020.
      More: https://is.muni.cz/publication/1298521/en
    6. HSP47 and FKBP65 cooperate in the synthesis of type I procollagen
      DURAN, Ivan, Lisette NEVAREZ, Anna SARUKHANOV, Sulin WU, Katrina LEE, Pavel KREJČÍ, Maryann WEIS, David EYRE, Deborah KRAKOW and Daniel H. COHN. HSP47 and FKBP65 cooperate in the synthesis of type I procollagen. Human Molecular Genetics. Oxford: Oxford Univ Press, 2015, vol. 24, No 7, p. 1918-1928. ISSN 0964-6906. Available from: https://dx.doi.org/10.1093/hmg/ddu608.
      More: https://is.muni.cz/publication/1218862/en
    7. Instability restricts signaling of multiple fibroblast growth factors
      BUCHTOVÁ, marcela, Radka CHALOUPKOVÁ, Malgorzata ZAKRZEWSKA, Iva VESELÁ, Petra CELÁ, Jana BARÁTHOVÁ, Iva GUDERNOVÁ, Renata ZAJICKOVA, Lukáš TRANTÍREK, Jorge MARTIN, Martin KOSTAS, Jacek OTLEWSKI, Jiří DAMBORSKÝ, Alois KOZUBÍK, Antoni WIEDLOCHA and Pavel KREJČÍ. Instability restricts signaling of multiple fibroblast growth factors. Cellular and Molecular Life Sciences. Basel: Springer, 2015, vol. 72, No 12, p. 2445-2459. ISSN 1420-682X. Available from: https://dx.doi.org/10.1007/s00018-015-1856-8.
      More: https://is.muni.cz/publication/1306872/en
    8. Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method
      BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Jana KOTAŠKOVÁ and Karla PLEVOVÁ. Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method. 2015.
      More: https://is.muni.cz/publication/1341556/en
    9. Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism
      WENDT, Daniel J., Melita DVORAK-EWELL, Sherry BULLENS, Florence LORGET, Sean M. BELL, Jeff PENG, Sianna CASTILLO, Mika AOYAGI-SCHARBER, Charles A. O'NEILL, Pavel KREJČÍ, William R. WILCOX, David L. RIMOIN and Stuart BUNTING. Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism. Journal of Pharmacology and Experimental Therapeutics. Bethesda: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 2015, vol. 353, No 1, p. 132-149. ISSN 0022-3565. Available from: https://dx.doi.org/10.1124/jpet.114.218560.
      More: https://is.muni.cz/publication/1298520/en
    10. Nové terapeutické možnosti achondroplázie a založení registru pro malé lidi v ČR
      SKUTKOVÁ, Linda, Martin PEŠL and Pavel KREJČÍ. Nové terapeutické možnosti achondroplázie a založení registru pro malé lidi v ČR. In XXXI. Neonatologické dny. 2015. ISSN 1211-1600.
      More: https://is.muni.cz/publication/1340322/en
    11. Příprava Registru Achondroplázie REACH
      PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ and Pavel KREJČÍ. Příprava Registru Achondroplázie REACH. In Celostátní konference Paleček 2015. 2015.
      More: https://is.muni.cz/publication/1380785/en
    12. Putting the brakes on chondrosarcoma
      KREJČÍ, Pavel. Putting the brakes on chondrosarcoma. Oncotarget. New York: Impact Journals, 2015, vol. 6, No 28, p. 24598. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.5242.
      More: https://is.muni.cz/publication/1316986/en

    2014

    1. Effect of FGFR inhibitors on chicken limb development
      HORAKOVA, Dana, Petra CELÁ, Pavel KREJČÍ, Lukáš BÁLEK, Simona MORAVCOVÁ BALKOVÁ, Eva MATALOVA and Marcela BUCHTOVA. Effect of FGFR inhibitors on chicken limb development. Development Growth & Differentiation. Hoboken, USA: WILEY-BLACKWELL, 2014, vol. 56, No 8, p. 555-572. ISSN 0012-1592. Available from: https://dx.doi.org/10.1111/dgd.12156.
      More: https://is.muni.cz/publication/1218005/en
    2. FGF19/BETA-KLOTHO REGULATE PHYSIOLOGY AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS
      BOSÁKOVÁ, Michaela, Pavel KREJČÍ, Lukáš TRANTÍREK and Petr DVOŘÁK. FGF19/BETA-KLOTHO REGULATE PHYSIOLOGY AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS. In ISSCR 12th Annual Meeting, Vancouver, Canada, June 18-21 2014. 2014.
      More: https://is.muni.cz/publication/1339565/en
    3. Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFbeta-Activated Kinase 1 Tyrosine Phosphorylation and NFkappaB Signaling in Multiple Myeloma and Bladder Cancer
      SALAZAR, Lisa, Tamar KASHIWADA, Pavel KREJČÍ, April MEYER, Malcolm CASALE, Matthew HALLOWELL, William WILCOX, Daniel DONOGHUE and Leslie MICHELS THOMPSON. Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFbeta-Activated Kinase 1 Tyrosine Phosphorylation and NFkappaB Signaling in Multiple Myeloma and Bladder Cancer. PLOS One. San Francisco: Public Library of Science, 2014, vol. 9, No 1, p. "nestrankovano", 13 pp. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0086470.
      More: https://is.muni.cz/publication/1168185/en
    4. Phenotype-genotype correlations in patients with Marinesco-Sjogren syndrome (Phenotype Genotype Correlations In Patients With The Marinesco-Sjögren Syndrome: Novel Findings and Review of The Literature)
      EZGU, F. S., Pavel KREJČÍ, S. LI, Carlos DE SOUSA, JM GRAHAM, I. HANSMANN, W. HE, K. PORPORA, Dorothea WAND, W. WERTELECKI, A. SCHNEIDER and William R. WILCOX. Phenotype-genotype correlations in patients with Marinesco-Sjogren syndrome (Phenotype Genotype Correlations In Patients With The Marinesco-Sjögren Syndrome: Novel Findings and Review of The Literature). Clinical Genetics. Hoboken: Wiley-Blackwell, 2014, vol. 86, No 1, p. 74-84. ISSN 0009-9163. Available from: https://dx.doi.org/10.1111/cge.12230.
      More: https://is.muni.cz/publication/1115831/en
    5. TEC KINASE MODULATES AUTOCRINE/PARACRINE FGF2 SIGNALING IN HUMAN PLURIPOTENT STEM CELLS
      KONEČNÁ, Žaneta, Tereza VÁŇOVÁ, Michaela BOSÁKOVÁ, Pavel KREJČÍ and Petr DVOŘÁK. TEC KINASE MODULATES AUTOCRINE/PARACRINE FGF2 SIGNALING IN HUMAN PLURIPOTENT STEM CELLS. In ISSCR 12th Annual Meeting, Vancouver, Canada, June 18-21 2014. 2014.
      More: https://is.muni.cz/publication/1339564/en
    6. The paradox of FGFR3 signaling in skeletal dysplasia: Why chondrocytes growth arrest while other cells over proliferate
      KREJČÍ, Pavel. The paradox of FGFR3 signaling in skeletal dysplasia: Why chondrocytes growth arrest while other cells over proliferate. Mutation Research - Reviews in Mutation Research. Amsterdam: Elsevier Science, 2014, vol. 759, January–March, p. 40-48. ISSN 1383-5742. Available from: https://dx.doi.org/10.1016/j.mrrev.2013.11.001.
      More: https://is.muni.cz/publication/1139209/en

    2013

    1. Expression of FGF19 in Human Embryonic Stem Cells
      KREJČÍ, Pavel, Michaela KUNOVÁ, Iva KUBÍKOVÁ, Lukáš TRANTÍREK, Alois KOZUBÍK and Petr DVOŘÁK. Expression of FGF19 in Human Embryonic Stem Cells. STEM CELLS. HOBOKEN: WILEY-BLACKWELL, 2013, vol. 31, No 11, p. 2582-2584. ISSN 1066-5099. Available from: https://dx.doi.org/10.1002/stem.1493.
      More: https://is.muni.cz/publication/1126953/en
    2. Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene.
      EZGU, Fatih, Pavel KREJČÍ and William R. WILCOX. Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene. Gene. Amsterdam: Elsevier, 2013, vol. 524, No 2, p. 403-406. ISSN 0378-1119. Available from: https://dx.doi.org/10.1016/j.gene.2013.03.026.
      More: https://is.muni.cz/publication/1115833/en
    3. The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
      KAUCKÁ, Markéta, Karla PLEVOVÁ, Šárka PAVLOVÁ, Pavlína JANOVSKÁ, Archana SHAIK, Jan VERNER, Jiřina PROCHÁZKOVÁ, Pavel KREJČÍ, Jana KOTAŠKOVÁ, Petra OVESNÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Alois KOZUBÍK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration. Cancer Research. USA: American Association for Cancer Research, 2013, vol. 73, No 5, p. 1491-1501. ISSN 0008-5472. Available from: https://dx.doi.org/10.1158/0008-5472.CAN-12-1752.
      More: https://is.muni.cz/publication/1091977/en

    2012

    1. Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo
      KOČÍ, Lenka, Katarína CHLEBOVÁ, Martina HÝŽĎALOVÁ, Jiřina HOFMANOVÁ, Miroslav JÍRA, Petr KYSELA, Alois KOZUBÍK, Zdeněk KALA and Pavel KREJČÍ. Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo. Oncology Letters. Spandidos Publ., 2012, vol. 3, No 4, p. 913-916. ISSN 1792-1074. Available from: https://dx.doi.org/10.3892/ol.2012.593.
      More: https://is.muni.cz/publication/981458/en
    2. Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling
      MERRILL, A.E., A. SARUKHANOV, Pavel KREJČÍ, B. IDONI, N. CAMACHO, K.D. ESTRADA, K.M. LYONS, H. DEIXLER, H. ROBINSON, D. CHITAYAT, C.J. CURRY, R.S. LACHMAN, W.R. WILCOX and D. KRAKOW. Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling. The American Journal of Human Genetics. Chicago: University of Chicago Press, 2012, vol. 90, No 3, p. 550-557. ISSN 0002-9297. Available from: https://dx.doi.org/10.1016/j.ajhg.2012.02.005.
      More: https://is.muni.cz/publication/980985/en
    3. Exome Sequencing Identifies PDE4D mutations in Acrodysostosis
      LEE, Hane, J.M. GRAHAM, D.L. RIMOIN, R.S. LACHMAN, Pavel KREJČÍ, S.W. TOMPSON, S.F. NELSON, D. KRAKOW and D.H. COHN. Exome Sequencing Identifies PDE4D mutations in Acrodysostosis. The American Journal of Human Genetics. Chicago: University of Chicago Press, 2012, vol. 90, No 4, p. 746-751. ISSN 0002-9297. Available from: https://dx.doi.org/10.1016/j.ajhg.2012.03.004.
      More: https://is.muni.cz/publication/980988/en
    4. p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
      WANG, Y., X. ZHOU, K. OBEROI, R. PHELPS, R. COUWENHOVEN, M. SUN, A. REZZA, G. HOLMES, Ch.J. PERCIVAL, J. FRIEDENTHAL, Pavel KREJČÍ, J.T. RICHTSMEIER, D.L. HUSO, Michael RENDL and E. WANG JABS. p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. The journal of clinical investigation. [New York, N.Y.]: American Society for Clinical Investigation, 2012, vol. 122, No 6, p. 2153-2164. ISSN 0021-9738. Available from: https://dx.doi.org/10.1172/JCI62644.
      More: https://is.muni.cz/publication/982600/en
    5. Receptor tyrosine kinases activate canonical WNT/beta catenin signaling via MAP kinase/LRP6 pathway and direct beta-Catenin phosphorylation
      KREJČÍ, Pavel, Anie AKLIAN, Markéta KAUCKÁ, Eva ŠEVČÍKOVÁ, Jiřina PROCHÁZKOVÁ, Pavol MIKOLKA, Lukáš BÁLEK, Tereza POSPÍŠILOVÁ, Tereza SPOUSTOVÁ, Vítězslav BRYJA, Iva VESELÁ, Alois KOZUBÍK, MaryAnn WEIS, W.A. PAZNEKAS, J.H. WOLF, J.S. GUTKIND, W.A. WILCOX, E. WNAG JABS, Lisa SALAZAR and Jan Kukla MAŠEK. Receptor tyrosine kinases activate canonical WNT/beta catenin signaling via MAP kinase/LRP6 pathway and direct beta-Catenin phosphorylation. Plos One. 2012, vol. 7, No 4, p. 1-14. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0035826.
      More: https://is.muni.cz/publication/980981/en
    6. Sixteen years and counting: the current understanding of fibroblast growth factorreceptor 3 (FGFR3) signaling in skeletal dysplasias.
      FOLDYNOVA-TRANTIRKOVA, Silvie, W.R. WILCOX and Pavel KREJČÍ. Sixteen years and counting: the current understanding of fibroblast growth factorreceptor 3 (FGFR3) signaling in skeletal dysplasias. Human Mutation. 2012, vol. 33, No 1, p. 29-41. ISSN 1059-7794. Available from: https://dx.doi.org/10.1002/humu.21636.
      More: https://is.muni.cz/publication/970743/en
    7. Způsob stanovení závažnosti a prognózy B-buněčné chronické lymfocytární leukémie (Method for magnitude and prognosis determination in B-cell chronic lymphocytic leukemia.)
      BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Karla MALINOVÁ and Jana KOTAŠKOVÁ. Způsob stanovení závažnosti a prognózy B-buněčné chronické lymfocytární leukémie (Method for magnitude and prognosis determination in B-cell chronic lymphocytic leukemia.). 2012.
      More: https://is.muni.cz/publication/1093630/en

    2011

    1. Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6
      ČERVENKA, Igor, Joshua WOLF, Jan MAŠEK, Pavel KREJČÍ, William R. WILCOX, Alois KOZUBÍK, Gunnar SCHULTE, Silvio J. GUTKIND and Vítězslav BRYJA. Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6. Molecular and cellular biology. 2011, vol. 31, No 1, p. 179-189. ISSN 0270-7306. Available from: https://dx.doi.org/10.1128/MCB.00550-10.
      More: https://is.muni.cz/publication/1094503/en
    2. Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6
      ČERVENKA, Igor, Joshua WOLF, Jan MAŠEK, Pavel KREJČÍ, William R WILCOX, Alois KOZUBÍK, Gunnar SCHULTE, J Silvio GUTKIND and Vítězslav BRYJA. Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6. January 2011. Washington, D.C.: ASM, 2011, vol. 31, No 1, p. 179-189. ISSN 0270-7306. Available from: https://dx.doi.org/10.1128/MCB.00550-10.
      More: https://is.muni.cz/publication/929220/en
    3. Post-translational modifications regulate signalling by Ror1
      KAUCKÁ, Markéta, Pavel KREJČÍ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Jiřina PROCHÁZKOVÁ, Pavlína JANOVSKÁ, Jana VALNOHOVÁ, Alois KOZUBÍK, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. Post-translational modifications regulate signalling by Ror1. Acta Physiologica. Oxford: Blackwell Publishing, 2011, vol. 203, No 3, p. 351-362. ISSN 1748-1708. Available from: https://dx.doi.org/10.1111/j.1748-1716.2011.02306.x.
      More: https://is.muni.cz/publication/961182/en
    4. Sequential activation and inactivation of dishevelled in the Wnt/{beta}-catenin pathway by casein kinases.
      BERNATÍK, Ondřej, Sri Ranjani GANJI, Jacomijn DIJKSTERHUIS, Peter KONIK, Igor ČERVENKA, Tilman POLONIO, Pavel KREJČÍ, Gunnar SCHULTE and Vítězslav BRYJA. Sequential activation and inactivation of dishevelled in the Wnt/{beta}-catenin pathway by casein kinases. Journal of Biological Chemistry. Bethesda, USA: Amer. Soc. Biochem. Mol. Biol., 2011, vol. 286, No 12, p. 10396-10410. ISSN 0021-9258. Available from: https://dx.doi.org/10.1074/jbc.M110.169870.
      More: https://is.muni.cz/publication/929228/en
    5. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting insuppression of human myeloma cell growth and survival.
      SCUTO, A., Pavel KREJČÍ, L. POPPLEWELL, J. WU, Y. WANG, M. KUJAWSKI, C. KOWOLIK, H. XIN, L. CHEN, Y. WANG, L. KRETZNER, H. YU, W.R. WILCOX, Y. YEN, S. FORMAN and R. JOVE. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting insuppression of human myeloma cell growth and survival. Leukemia. London : England: Nature Publishing Group, Specialist Jour, 2011, vol. 25, No 3, p. 538-550. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/leu.2010.289.
      More: https://is.muni.cz/publication/971588/en
    6. Wnt/PCP pathway regulates B-cell migration in chronic lymphocytic leukemia
      KAUCKÁ, Markéta, Jan VERNER, Jiřina PROCHÁZKOVÁ, Karla PLEVOVÁ, Olga STEHLÍKOVÁ, Pavel KREJČÍ, Alois KOZUBÍK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. Wnt/PCP pathway regulates B-cell migration in chronic lymphocytic leukemia. In XIV. International workshop on chronic lymphocytic leukemia in Clinical Lymphoma, Myeloma and Leukemia. 2011. ISSN 2152-2650.
      More: https://is.muni.cz/publication/966242/en

    2010

    1. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.
      FOLDYNOVÁ-TRANTÍRKOVÁ, S., P. SEKYROVÁ, Kateřina TMEJOVÁ, E. BRUMOVSKÁ, Ondřej BERNATÍK, W. BLANKENFELDT, Pavel KREJČÍ, Alois KOZUBÍK, T. DOLEZAL, Lukáš TRANTÍREK and Vítězslav BRYJA. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Research. London, Great Britain: Biomed Central Ltd., 2010, vol. 2010, 12/3, p. 30-31. ISSN 1465-5411. Available from: https://dx.doi.org/10.1186/bcr2581.
      More: https://is.muni.cz/publication/929226/en
    2. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence
      KREJČÍ, Pavel, Jiřina PROCHÁZKOVÁ, Jiří SMUTNÝ, Katarína CHLEBOVÁ, Patricia LIN, Anie AKLIAN, Vítězslav BRYJA, Alois KOZUBÍK and William R. WILCOX. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone. USA: Elsevier Science, 2010, neuveden, No 47, p. 102-110. ISSN 8756-3282.
      More: https://is.muni.cz/publication/889689/en
    3. Negative regulation of Wnt signaling mediated by CK1- phosphorylated Dishevelled via Ror2
      WITTE, Florian, Ondřej BERNATÍK, Katharina KIRCHNER, Jan MAŠEK, Annika MAHL, Pavel KREJČÍ, Stefan MUNDLOS, Alexandra SCHAMBONY, Vítězslav BRYJA and Sigmar STRICKER. Negative regulation of Wnt signaling mediated by CK1- phosphorylated Dishevelled via Ror2. FASEB JOURNAL. 2010, vol. 24, No 7, p. 2417-2426. ISSN 0892-6638. Available from: https://dx.doi.org/10.1096/fj.09-150615.
      More: https://is.muni.cz/publication/901334/en
    4. Nf449 is a novel inhibitor of fibroblast growth factor receptor 3 (fgfr3) signaling active in chondrocytes and multiple myeloma cells
      KREJČÍ, Pavel, Shunichi MURAKAMI, Jiřina PROCHÁZKOVÁ, Lukáš TRANTÍREK, Katarína CHLEBOVÁ, Zhufeng OUYANG, Anie AKLIAN, Jiří SMUTNÝ, Vítězslav BRYJA, Alois KOZUBÍK and Wiliam R. WILCOX. Nf449 is a novel inhibitor of fibroblast growth factor receptor 3 (fgfr3) signaling active in chondrocytes and multiple myeloma cells. J. Biol. Chem. 2010, vol. 285, No 27, p. 20644-20653. ISSN 0021-9258. Available from: https://dx.doi.org/10.1074/jbc.M109.083626.
      More: https://is.muni.cz/publication/927129/en

    2009

    1. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway
      MATSUSHITA, Takehiko, William WILCOX, Chan YUK YU, Aya KAWANAMI, Hülya BÜKÜLMEZ, Gener BALMES, Pavel KREJČÍ, Pertchoui B MEKIKIAN, Kazuyuki OTANI, Isakichi YAMAURA, Matthew L. WARMAN, David GIVOL and Shunichi MURAKAMI. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Human Molecular Genetics. 2009, vol. 18, No 2, 227-240. ISSN 0964-6906.
      More: https://is.muni.cz/publication/879423/en
    2. Fibroblast growth factor inhibits interferon gama-STAT1 and interleukin 6-STAT3 signaling in chondrocytes
      KREJČÍ, Pavel, Jiřina PROCHÁZKOVÁ, Vítězslav BRYJA, Petra JELÍNKOVÁ, Kateřina PEJCHALOVÁ, Alois KOZUBÍK, Leslie Michels TOMPSON and William R. WILCOX. Fibroblast growth factor inhibits interferon gama-STAT1 and interleukin 6-STAT3 signaling in chondrocytes. Cellular Signalling. 2009, vol. 21, No 1, p. 151-160. ISSN 0898-6568. Available from: https://dx.doi.org/10.1016/j.cellsig.2008.10.006.
      More: https://is.muni.cz/publication/816480/en
    3. High molecular weight FGF2: the biology of a nuclear growth factor
      CHLEBOVÁ, Katarína, Vítězslav BRYJA, Petr DVOŘÁK, Alois KOZUBÍK, W.R. WILCOX and Pavel KREJČÍ. High molecular weight FGF2: the biology of a nuclear growth factor. Cellular and molecular life sciences : CMLS. Switzerland, 2009, vol. 66, No 2, p. 225-235. ISSN 1420-682X. Available from: https://dx.doi.org/10.1007/s00018-008-8440-4.
      More: https://is.muni.cz/publication/828354/en
    4. Molecular pathology of the fibroblast growth factor family.
      KREJČÍ, Pavel, Jiřina PROCHÁZKOVÁ, Vítězslav BRYJA, Alois KOZUBÍK and William WILCOX. Molecular pathology of the fibroblast growth factor family. Human Mutation. 2009, vol. 30, No 9, p. 1245-55, 11 pp. ISSN 1059-7794. Available from: https://dx.doi.org/10.1002/humu.21067.
      More: https://is.muni.cz/publication/851988/en

    2008

    1. A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells
      SALAZAR, Lisa, Tamara KASHIWADA, Pavel KREJČÍ, Paul MUCHOWSKI, Daniel DONOGHUE, William WILCOX and Leslie Michels THOMPSON. A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. HUMAN MOLECULAR GENETICS. 2008, vol. 18, No 11, p. 1951-1961. ISSN 0964-6906.
      More: https://is.muni.cz/publication/879411/en
    2. Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage
      KREJČÍ, Pavel, Lisa SALAZAR, Tamara A. KASHIWADA, Katarína CHLEBOVÁ, Alena SALAŠOVÁ, Leslie Michels THOMPSON, Vítězslav BRYJA, Alois KOZUBÍK and William R. WILCOX. Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage. PLoS ONE. 2008, vol. 3, No 12, p. 72-81, 8 pp. ISSN 1932-6203.
      More: https://is.muni.cz/publication/818205/en
    3. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
      KREJČÍ, Pavel, Lisa SALAZAR, Helen GOODRIDGE, Tamara KASHIWADA, Matthew SCHIBLER, Petra JELÍNKOVÁ, Leslie Michels THOMPSON, and William WILCOX. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. JOURNAL OF CELL SCIENCE. 2008, vol. 121, No 3, p. 272-81, 11 pp. ISSN 0021-9533.
      More: https://is.muni.cz/publication/879430/en

    2007

    1. C-natriuretic peptide: an important regulator of cartilage.
      PEJCHALOVÁ, Kateřina, Pavel KREJČÍ and William R. WILCOX. C-natriuretic peptide: an important regulator of cartilage. Molecular Genetics and Metabolism. Elsevier, 2007, vol. 92, No 3, p. 210-215. ISSN 1096-7192. Available from: https://dx.doi.org/10.1016/j.ymgme.2007.06.014.
      More: https://is.muni.cz/publication/971615/en
    2. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligandsexpressed in human fetal growth plate cartilage.
      KREJČÍ, Pavel, D. KRAKOW, P.B. MEKIKIAN and William R. WILCOX. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligandsexpressed in human fetal growth plate cartilage. Pediatric Research. Rotterdam: Williams and Wilkins, 2007, vol. 61, No 3, p. 267-272. ISSN 0031-3998. Available from: https://dx.doi.org/10.1203/pdr.0b013e318030d157.
      More: https://is.muni.cz/publication/971676/en
    3. Simple, mammalian cell-based assay for identification of inhibitors of the ErkMAP kinase pathway.
      KREJČÍ, Pavel, Kateřina PEJCHALOVÁ and William R. WILCOX. Simple, mammalian cell-based assay for identification of inhibitors of the ErkMAP kinase pathway. Investigational New Drugs. 2007, vol. 25, No 4, p. 391-395. ISSN 0167-6997. Available from: https://dx.doi.org/10.1007/s10637-007-9054-7.
      More: https://is.muni.cz/publication/971626/en
    4. The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.
      KREJČÍ, Pavel, Kateřina PEJCHALOVÁ, B.E. ROSENBLOOM, F.P. ROSENFELT, E.L. TRAN, H. LAURELL and W.R. WILCOX. The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. Journal of Leukocyte Biology. New York: Society for Leukocyte Biology, 2007, vol. 82, No 6, p. 1363-1364. ISSN 0741-5400. Available from: https://dx.doi.org/10.1189/jlb.0607425.
      More: https://is.muni.cz/publication/971610/en

    2006

    1. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.
      KREJČÍ, Pavel, B. MASRI, L. SALAZAR, C. FARRINGTON-ROCK, H. PRATS, L.M. THOMPSON and W.R. WILCOX. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins. Journal of Biological Chemistry. Bethesda, USA: Amer. Soc. Biochem. Mol., 2006, vol. 282, No 5, p. 2929-2936. ISSN 0021-9258. Available from: https://dx.doi.org/10.1074/jbc.M606144200.
      More: https://is.muni.cz/publication/971677/en
    2. The fibroblast growth factors in multiple myeloma
      KREJČÍ, Pavel, PB MEKIKIAN and WR WILCOX. The fibroblast growth factors in multiple myeloma. Leukemia. 2006, vol. 20, No 6, p. 1165-1168. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/sj.leu.2404202.
      More: https://is.muni.cz/publication/1092036/en

    2005

    1. Interaction of fibroblast growth factor and C-natriuretic peptide signaling inregulation of chondrocyte proliferation and extracellular matrix homeostasis.
      KREJČÍ, Pavel, B. MASRI, V. FONTAINE, P.B. MEKIKIAN, M. WEIS, H. PRATS and W.R. WILCOX. Interaction of fibroblast growth factor and C-natriuretic peptide signaling inregulation of chondrocyte proliferation and extracellular matrix homeostasis. Journal of Cell Science. Cambridge: Company of Biologists Ltd., 2005, vol. 118, No 21, p. 5089-5100. ISSN 0021-9533. Available from: https://dx.doi.org/10.1242/jcs.02618.
      More: https://is.muni.cz/publication/971680/en

    2004

    1. FGFs inhibit proliferation and alter the cartilage-like phenotype of RCS cells
      KREJČÍ, Pavel, Vítězslav BRYJA, Jiří PACHERNÍK, Aleš HAMPL, R. POGUE and W.R. WILCOX. FGFs inhibit proliferation and alter the cartilage-like phenotype of RCS cells. Experimental Cell Research. Elsevier, 2004, vol. 297, p. 152-164. ISSN 0014-4827.
      More: https://is.muni.cz/publication/745002/en
    2. Mutations in the EVC1 gene are not a common finding in the Ellis-van Creveld and short rib-polydactyly type III syndromes.
      TAKAMINE, Y., Pavel KREJČÍ, P.B. MEKIKIAN and William R. WILCOX. Mutations in the EVC1 gene are not a common finding in the Ellis-van Creveld and short rib-polydactyly type III syndromes. American Journal of Medical Genetics. USA: Wiley-Liss, Inc., 2004, 130A, No 1, p. 96-97. ISSN 0148-7299. Available from: https://dx.doi.org/10.1002/ajmg.a.20579.
      More: https://is.muni.cz/publication/971682/en
    3. The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo
      BRYJA, Vítězslav, Jiří PACHERNÍK, Ludmila FALDÍKOVÁ, Pavel KREJČÍ, R, POGUE, I, NEVRIVA, Petr DVOŘÁK and Aleš HAMPL. The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo. Biochimica et biophysica acta : Molecular Cell Research. Amsterdam: Elsevier, 2004, vol. 1691, 2-3, p. 105-116. ISSN 0167-4889. Available from: https://dx.doi.org/10.1016/j.bbamer.2004.01.001.
      More: https://is.muni.cz/publication/1092039/en

    2003

    1. FGF-2 expression and its action in human leukemia and lymphoma cell lines
      KREJČÍ, Pavel, Jana MILFAITOVÁ, H. LAURELL, Aleš HAMPL and Petr DVOŘÁK. FGF-2 expression and its action in human leukemia and lymphoma cell lines. Leukemia. London : England: Nature Publishing Group, Specialist Jour, 2003, vol. 17, No 4, p. 818-820. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/sj.leu.2402861.
      More: https://is.muni.cz/publication/971685/en

    2002

    1. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells
      PRECLÍKOVÁ, H., Vítězslav BRYJA, Jiří PACHERNÍK, Pavel KREJČÍ, Petr DVOŘÁK and Aleš HAMPL. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells. Cell Growth and Differentiation. 2002, vol. 13, p. 421-430. ISSN 1044-9523.
      More: https://is.muni.cz/publication/744996/en
    2. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.
      PRECLÍKOVÁ, H., Vítězslav BRYJA, Jiří PACHERNÍK, Pavel KREJČÍ, Petr DVOŘÁK and Aleš HAMPL. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells. Cell Growth and Differentiation. 2002, 130A, No 9, p. 421-430. ISSN 1044-9523.
      More: https://is.muni.cz/publication/971687/en

    2001

    1. FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias
      KREJČÍ, Pavel, D. DVORÁKOVÁ, E. KRAHULCOVÁ, Jiří PACHERNÍK, Jiří MAYER, Aleš HAMPL and Petr DVOŘÁK. FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias. Leukemia. London : England: Nature Publishing Group, Specialist Jour, 2001, vol. 15, No 2, p. 228-237. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/sj.leu.2402012.
      More: https://is.muni.cz/publication/971692/en
    2. Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells
      DVORAKOVA, D., Pavel KREJČÍ, Jiří MAYER, Jiří FAJKUS, Aleš HAMPL and Petr DVOŘÁK. Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells. British journal of haematology. England: Wiley-Blackwell, 2001, vol. 113, No 3, p. 832-835. ISSN 0007-1048. Available from: https://dx.doi.org/10.1046/j.1365-2141.2001.02829.x.
      More: https://is.muni.cz/publication/971689/en
    3. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells
      VONDRÁČEK, Jan, M.A. SHEARD, Pavel KREJČÍ, Kateřina MINKSOVÁ, Jiřina HOFMANOVÁ and Alois KOZUBÍK. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells. Journal of Leukocyte Biology. New York: Society for Leukocyte Biology, 2001, vol. 69, No 5, p. 794-802. ISSN 0741-5400.
      More: https://is.muni.cz/publication/971690/en

    1999

    1. O-linked carbohydrates are required for FGF-2-mediated proliferation of mouse embryonic cells.
      JIRMANOVA, L., Jiřina PACHOLÍKOVÁ, Pavel KREJČÍ, A HAMPL and Petr DVOŘÁK. O-linked carbohydrates are required for FGF-2-mediated proliferation of mouse embryonic cells. The International journal of developmental biology. Spain: University Of The Basque Country Press, 1999, vol. 43, No 6, p. 555-562. ISSN 0214-6282.
      More: https://is.muni.cz/publication/971694/en
Display details
Displayed: 26/4/2024 17:47